282 related articles for article (PubMed ID: 15607883)
1. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model.
Haupt JL; Frisbie DD; McIlwraith CW; Robbins PD; Ghivizzani S; Evans CH; Nixon AJ
J Orthop Res; 2005 Jan; 23(1):118-26. PubMed ID: 15607883
[TBL] [Abstract][Full Text] [Related]
2. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
Nixon AJ; Haupt JL; Frisbie DD; Morisset SS; McIlwraith CW; Robbins PD; Evans CH; Ghivizzani S
Gene Ther; 2005 Jan; 12(2):177-86. PubMed ID: 15578043
[TBL] [Abstract][Full Text] [Related]
3. Gene mediated insulin-like growth factor-I delivery to the synovium.
Saxer RA; Bent SJ; Brower-Toland BD; Mi Z; Robbins PD; Evans CH; Nixon AJ
J Orthop Res; 2001 Sep; 19(5):759-67. PubMed ID: 11562119
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 and corticosteroid modulation of chondrocyte metabolic and mitogenic activities in interleukin 1-conditioned equine cartilage.
Frisbie DD; Nixon AJ
Am J Vet Res; 1997 May; 58(5):524-30. PubMed ID: 9140562
[TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
6. Direct adenovirus-mediated IGF-I gene transduction of synovium induces persisting synovial fluid IGF-I ligand elevations.
Goodrich LR; Brower-Toland BD; Warnick L; Robbins PD; Evans CH; Nixon AJ
Gene Ther; 2006 Sep; 13(17):1253-62. PubMed ID: 16708081
[TBL] [Abstract][Full Text] [Related]
7. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model.
Goodrich LR; Hidaka C; Robbins PD; Evans CH; Nixon AJ
J Bone Joint Surg Br; 2007 May; 89(5):672-85. PubMed ID: 17540757
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I gene expression patterns during spontaneous repair of acute articular cartilage injury.
Fortier LA; Balkman CE; Sandell LJ; Ratcliffe A; Nixon AJ
J Orthop Res; 2001 Jul; 19(4):720-8. PubMed ID: 11518284
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the catabolic effects of interleukin-1beta on proteoglycan metabolism in equine cartilage cocultured with synoviocytes.
Gregg AJ; Fortier LA; Mohammed HO; Mayr KG; Miller BJ; Haupt JL
Am J Vet Res; 2006 Jun; 67(6):957-62. PubMed ID: 16740087
[TBL] [Abstract][Full Text] [Related]
10. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes.
Loeser RF; Pacione CA; Chubinskaya S
Arthritis Rheum; 2003 Aug; 48(8):2188-96. PubMed ID: 12905472
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional and proteolytic regulation of the insulin-like growth factor-I system of equine articular chondrocytes by recombinant equine interleukin-1beta.
Porter RM; Akers RM; Howard RD; Forsten-Williams K
J Cell Physiol; 2006 Nov; 209(2):542-50. PubMed ID: 16897751
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
13. IL-1ra/IGF-1 gene therapy modulates repair of microfractured chondral defects.
Morisset S; Frisbie DD; Robbins PD; Nixon AJ; McIlwraith CW
Clin Orthop Relat Res; 2007 Sep; 462():221-8. PubMed ID: 17534189
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
Guo WS; Ma L; Li ZR
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage.
Wang J; Elewaut D; Veys EM; Verbruggen G
Arthritis Rheum; 2003 May; 48(5):1281-91. PubMed ID: 12746901
[TBL] [Abstract][Full Text] [Related]
16. [Construction and identification of recombinant retroviral vector containing human interleukin 1 receptor antagonist and its expression in osteoarthritic human articular chondrocytes].
Rui Y; Wang Y; Zhang X; Sun H; Qu Z; Dai K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 May; 22(5):533-8. PubMed ID: 18630429
[TBL] [Abstract][Full Text] [Related]
17. Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites.
Nixon AJ; Fortier LA; Williams J; Mohammed H
J Orthop Res; 1999 Jul; 17(4):475-87. PubMed ID: 10459752
[TBL] [Abstract][Full Text] [Related]
18. Coordinate upregulation of cartilage matrix synthesis in fibrin cultures supplemented with exogenous insulin-like growth factor-I.
Fortier LA; Lust G; Mohammed HO; Nixon AJ
J Orthop Res; 1999 Jul; 17(4):467-74. PubMed ID: 10459751
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation.
Clutterbuck AL; Mobasheri A; Shakibaei M; Allaway D; Harris P
Ann N Y Acad Sci; 2009 Aug; 1171():428-35. PubMed ID: 19723086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
